Literature DB >> 29257202

Overexpression of microRNA-146 protects against oxygen-glucose deprivation/recovery-induced cardiomyocyte apoptosis by inhibiting the NF-κB/TNF-α signaling pathway.

Wenwu Zhang1, Mengmeng Shao2, Xiaojie He3, Benji Wang1, Yuechun Li4, Xianyang Guo1.   

Abstract

MicroRNA (miR) has been reported to be associated with ischemia and reperfusion (I/R) and cell apoptosis. Suppression of cell apoptosis may reduce the irreversible damage induced by reperfusion. The aims of the current study were to explore the cytoprotective effects of miR-146 against oxygen-glucose deprivation/recovery (OGD/R)-induced injury in H9c2 rat myocardial cells, as well as the underlying mechanisms. Following stimulation with OGD/R, the cells were transfected with miR-146 mimics or negative controls. The levels of miR-146 were analyzed by reverse transcription-quantitative polymerase chain reaction. Thereafter, cell viability and cell apoptosis were analyzed by MTT assay and terminal deoxynucleotidyl-transferase-mediated dUTP nick-end labeling assay, respectively. In addition, the levels of tumor necrosis factor (TNF)-α were determined by ELISA and the levels of B-cell lymphoma 2 (Bcl-2)-associated X protein (Bax), Bcl-2 and phosphorylated (p)-nuclear factor (NF)-κB were measured by western blotting. The results demonstrated that overexpression of miR-146 significantly increased cell viability and decreased apoptosis (P<0.05). It was observed that overexpression of miR-146 statistically reduced the levels of Bax, TNF-α and p-NF-κB but markedly upregulated the levels of Bcl-2 (P<0.05). These results indicate that overexpression of miR-146 may protect against OGD/R-induced cardiomyocyte apoptosis. Overexpression of miR-146 may alleviate the irreversible injury associated with reperfusion and the effects may be achieved by inhibiting the NF-κB/TNF-α signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29257202     DOI: 10.3892/mmr.2017.8073

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  10 in total

Review 1.  MicroRNAs as Potential Pharmaco-targets in Ischemia-Reperfusion Injury Compounded by Diabetes.

Authors:  Hassan Dehaini; Hussein Awada; Ahmed El-Yazbi; Fouad A Zouein; Khodr Issa; Assaad A Eid; Maryam Ibrahim; Adnan Badran; Elias Baydoun; Gianfranco Pintus; Ali H Eid
Journal:  Cells       Date:  2019-02-12       Impact factor: 6.600

2.  MicroRNA-146 attenuates lipopolysaccharide induced ovarian dysfunction by inhibiting the TLR4/NF- κB signaling pathway.

Authors:  Fengping He; Yanhui Liu; Tang Li; Qiulin Ma; Zhang Yongmei; Peiqing He; Chuanyin Xiong
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Circular RNA Fbxl5 Regulates Cardiomyocyte Apoptosis During Ischemia Reperfusion Injury via Sponging microRNA-146a.

Authors:  Dongjiu Li; Jiayin You; Chengyu Mao; En Zhou; Zhihua Han; Junfeng Zhang; Tiantian Zhang; Changqian Wang
Journal:  J Inflamm Res       Date:  2022-04-21

4.  Dexmedetomidine targets miR-146a and participates in the progress of chronic obstructive pulmonary disease in vivo and in vitro.

Authors:  Na Li; Shuangfeng Li; Yehua Wu; Lu Xiong; Tiejun Li; Dandan Xing; Qiuchang Li; Duozhi Wu
Journal:  Genes Genomics       Date:  2021-01-22       Impact factor: 1.839

5.  Andrographolide inhibits breast cancer through suppressing COX-2 expression and angiogenesis via inactivation of p300 signaling and VEGF pathway.

Authors:  Yulin Peng; Yan Wang; Ning Tang; Dongdong Sun; Yulong Lan; Zhenlong Yu; Xinyu Zhao; Lei Feng; Baojing Zhang; Lingling Jin; Fabiao Yu; Xiaochi Ma; Chuanzhu Lv
Journal:  J Exp Clin Cancer Res       Date:  2018-10-12

6.  Cyclosporine A eyedrops with self-nanoemulsifying drug delivery systems have improved physicochemical properties and efficacy against dry eye disease in a murine dry eye model.

Authors:  Seung Pil Bang; Chang Yeor Yeon; Nirpesh Adhikari; Sanjiv Neupane; Harim Kim; Dong Cheol Lee; Myeong Jin Son; Hyun Gyo Lee; Jae-Young Kim; Jong Hwa Jun
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

7.  Rosuvastatin Attenuates Myocardial Ischemia-Reperfusion Injury via Upregulating miR-17-3p-Mediated Autophagy.

Authors:  Xiaoqin Wang; Jinghan Chen; Xiaojiao Huang
Journal:  Cell Reprogram       Date:  2019-11-15       Impact factor: 1.987

8.  miR-146a-5p-mediated suppression on trophoblast cell progression and epithelial-mesenchymal transition in preeclampsia.

Authors:  Pingping Peng; Huamei Song; Chenghong Xie; Wenfei Zheng; Huigai Ma; Dandan Xin; Jingqiong Zhan; Xiaoqing Yuan; Aihua Chen; Jing Tao; Jufang Qin
Journal:  Biol Res       Date:  2021-09-13       Impact factor: 5.612

Review 9.  Diagnostic, Prognostic, and Therapeutic Value of Non-Coding RNA Expression Profiles in Renal Transplantation.

Authors:  Adriana Franco-Acevedo; Zesergio Melo; Raquel Echavarria
Journal:  Diagnostics (Basel)       Date:  2020-01-22

Review 10.  Impact of the Main Cardiovascular Risk Factors on Plasma Extracellular Vesicles and Their Influence on the Heart's Vulnerability to Ischemia-Reperfusion Injury.

Authors:  Miłosz Majka; Marcin Kleibert; Małgorzata Wojciechowska
Journal:  Cells       Date:  2021-11-27       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.